New drug combo targets Hard-to-Treat brain tumors
Disease control
Ongoing
This study investigates whether combining ACT001 (an oral drug) with pembrolizumab (an immunotherapy) can help people with recurrent glioblastoma, an aggressive brain cancer. Participants take the drugs before surgery to remove their tumor, allowing researchers to analyze how the…
Phase: PHASE1, PHASE2 • Sponsor: Accendatech USA Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC